[Pharmacokinetic study of piperacillin in the field of obstetrics and gynecology].
The following trial was conducted as a fundamental study in the application of piperacillin (PIPC) in the field of obstetrics and gynecology. A dose of 1 g was administered to 10 patients by intravenous injection and the concentrations of PIPC in the serum and the various tissues of the uterus were measured. This data was analyzed by the computer. 1. These concentrations were analyzed based on a two- or three-compartment model. We obtained the pharmacokinetic parameters and described the simulation curves. Correspondence was observed between the calculated and the actually determined concentrations. 2. PIPC was rapidly distributed to the tissues of the uterus and exhibited high concentrations. Transfer to these tissues correlated well with serum concentrations.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000378:metabolism*; D002584:Cervix Uteri / Q000378:metabolism; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007700:Kinetics; D008875:Middle Aged; D009215:Myometrium / Q000378:metabolism; D010053:Ovary / Q000378:metabolism*; D010406:Penicillins / Q000378:metabolism*; D010878:Piperacillin; D014599:Uterus / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D010406:Penicillins; D010878:Piperacillin